Clinical Approach to Non-Healing Ulcer / Wound

Comprehensive Practical Framework

1
Symptom Overview
Overview
2
Pathophysiology
Mechanism
3
History Taking
History
4
Physical Examination
Examination
5
Differential Diagnosis
Differential
6
Investigations
Workup
7
Clinical Decision-Making
Algorithm
8
Pearls and Pitfalls
Summary

1. Symptom Overview

Understanding the clinical significance and classification of non-healing ulcers and wounds

Chronic non-healing wounds represent a significant healthcare burden, affecting approximately 1 to 2% of the population in developed countries. In the United States alone, chronic wounds affect an estimated 6.5 million patients annually, with healthcare costs exceeding $25 billion per year. The prevalence increases dramatically with age, affecting up to 5% of individuals over 65 years. Lower extremity ulcers account for approximately 70% of all chronic wounds, with venous leg ulcers being the most common type (approximately 70% of leg ulcers), followed by arterial ulcers (10 to 15%) and diabetic foot ulcers (15 to 25% of diabetic patients will develop a foot ulcer in their lifetime).

Definition

A non-healing wound (chronic wound) is defined as a wound that fails to progress through the normal, orderly, and timely sequence of tissue repair, or a wound that proceeds through the repair process without restoring anatomic and functional integrity. By convention, a wound is considered chronic if it has not healed within 4 to 6 weeks despite appropriate standard care, or if it shows no significant progress toward healing over a 2-week observation period.

Classification by Duration

Category	Duration	Common Causes	Clinical Significance
Acute Wound	Less than 2 weeks	Surgical incisions, traumatic lacerations, burns, abrasions	Expected to heal through normal repair phases; requires monitoring for signs of delayed healing
Subacute Wound	2 to 6 weeks	Wounds with early signs of impaired healing, minor infections, suboptimal local wound care	Critical observation period; intervention at this stage can prevent chronicity
Chronic Wound	Greater than 6 weeks	Venous insufficiency, arterial disease, diabetes mellitus, pressure injury, inflammatory conditions	Requires comprehensive evaluation for underlying etiology; multidisciplinary approach often needed

Classification by Etiology

Vascular Ulcers

Venous ulcers: Result from chronic venous insufficiency and sustained venous hypertension. Typically located in the gaiter area (medial malleolus), shallow with irregular borders, and associated with surrounding lipodermatosclerosis and hemosiderin staining.

Arterial ulcers: Result from peripheral arterial disease causing tissue ischemia. Typically located on distal extremities (toes, heel, lateral malleolus), with well-demarcated “punched-out” appearance, pale wound bed, and significant pain.

Metabolic and Neuropathic Ulcers

Diabetic foot ulcers: Result from a combination of peripheral neuropathy, microangiopathy, and altered biomechanics. Typically located at pressure points (metatarsal heads, heel), often painless due to neuropathy, with surrounding callus formation.

Pressure ulcers: Result from sustained pressure causing tissue ischemia. Located over bony prominences (sacrum, heels, ischial tuberosities), classified by depth of tissue involvement (Stages 1 through 4).

Classification by Wound Bed Appearance

Tissue Type	Color	Description	Clinical Implication
Necrotic (Eschar)	Black or brown	Dry, leathery, adherent dead tissue	Requires debridement before healing can occur; assess for underlying infection
Slough	Yellow or tan	Moist, stringy, fibrinous tissue	Contains dead cells and debris; removal promotes granulation
Granulating	Beefy red	Moist, bumpy, highly vascular tissue	Indicates active healing; protect and maintain moist environment
Epithelializing	Pink or pearl	New skin growing from wound edges or islands	Final healing phase; protect from trauma and maintain hydration
Hypergranulating	Dark red, friable	Granulation tissue above wound margins	Prevents epithelialization; may indicate infection, foreign body, or excess moisture

Classification by Anatomical Location

Location	Most Likely Etiology	Characteristic Features
Medial lower leg (gaiter area)	Venous insufficiency	Shallow, irregular, with surrounding skin changes
Lateral malleolus, toes, heel	Arterial insufficiency	Punched-out, deep, painful, pale base
Plantar surface of foot	Diabetic neuropathy	Painless, surrounded by callus, over pressure points
Sacrum, ischium, heels	Pressure injury	Over bony prominences, in immobile patients
Pretibial area	Trauma, necrobiosis lipoidica (in diabetics)	History of minor trauma, slow to heal
Any location with atypical features	Malignancy, vasculitis, pyoderma gangrenosum	Unusual appearance, rapid progression, rolled edges, failure to respond to standard treatment

The “Big Four” Etiologies: In clinical practice, four conditions account for the vast majority of chronic lower extremity ulcers: venous insufficiency (approximately 70%), arterial disease (10 to 15%), diabetic neuropathy (15 to 25% of diabetics), and pressure. However, approximately 15 to 20% of chronic wounds have mixed etiology, most commonly combined arteriovenous disease. Always consider that multiple factors may be contributing to impaired wound healing.

Impact on Quality of Life

Beyond the Wound

Chronic wounds significantly impact patient quality of life through multiple domains:

Pain: Present in up to 75% of patients with chronic wounds, often undertreated
Mobility: Reduced ambulation, loss of independence, social isolation
Psychological: Depression (up to 30%), anxiety, altered body image, fear of amputation
Economic: Lost work days, cost of dressings and medical visits, caregiver burden
Odor and exudate: Social embarrassment, difficulty with wound management

2. Pathophysiology and Mechanisms

Understanding the normal wound healing process and mechanisms of impairment

Normal wound healing is a complex, highly coordinated biological process involving the interaction of cells, growth factors, cytokines, and extracellular matrix components. Understanding the phases of normal healing is essential for recognizing where the process can fail and why wounds become chronic. Chronic wounds are characterized by a persistent inflammatory state, failure to re-epithelialize, and an imbalance between tissue destruction and repair.

The Four Phases of Normal Wound Healing

Phase	Timing	Key Events	Key Cells and Mediators
1. Hemostasis	Immediate (minutes to hours)	Vasoconstriction, platelet aggregation, fibrin clot formation, provisional matrix established	Platelets, fibrinogen, thrombin, platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β)
2. Inflammation	Hours to days (Day 1-4)	Vasodilation, increased permeability, neutrophil infiltration (early), macrophage recruitment (later), bacterial clearance, debris removal	Neutrophils, macrophages, mast cells, interleukins (IL-1, IL-6), tumor necrosis factor-alpha (TNF-α)
3. Proliferation	Days to weeks (Day 4-21)	Granulation tissue formation, angiogenesis, fibroblast proliferation, collagen synthesis, wound contraction, re-epithelialization	Fibroblasts, keratinocytes, endothelial cells, vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF)
4. Remodeling	Weeks to years (Day 21 onward)	Collagen reorganization (type III replaced by type I), scar maturation, increased tensile strength (maximum 80% of original)	Fibroblasts, matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs)

Pathophysiology of Chronic Wounds: Where Healing Fails

The Chronic Wound Microenvironment: Chronic wounds are characterized by:

Prolonged and excessive inflammation with elevated pro-inflammatory cytokines
Elevated levels of matrix metalloproteinases (MMPs) that degrade growth factors and extracellular matrix
Reduced levels of tissue inhibitors of metalloproteinases (TIMPs)
Cellular senescence of fibroblasts with reduced proliferative and synthetic capacity
Biofilm formation creating persistent bacterial colonization resistant to antibiotics
Hypoxia and inadequate nutrient delivery to the wound bed

How Specific Conditions Impair Wound Healing

Condition	Primary Mechanism of Impairment	Key Pathophysiological Features
Chronic Venous Insufficiency	Sustained venous hypertension and inflammation	Valve incompetence leads to venous hypertension → capillary distension → fibrin cuff deposition around capillaries → leukocyte trapping and activation → chronic inflammation → tissue damage and ulceration
Peripheral Arterial Disease	Tissue ischemia from inadequate oxygen and nutrient delivery	Atherosclerotic narrowing reduces perfusion → inadequate oxygen for cellular metabolism and collagen synthesis → impaired neutrophil and macrophage function → reduced resistance to infection → tissue necrosis
Diabetes Mellitus	Multifactorial: neuropathy, microangiopathy, immune dysfunction, hyperglycemia	Peripheral neuropathy → loss of protective sensation → unrecognized repetitive trauma; Microangiopathy → reduced perfusion; Hyperglycemia → impaired neutrophil function, non-enzymatic glycation of proteins, advanced glycation end products (AGEs) → impaired collagen function
Pressure Injury	Sustained pressure causing ischemia-reperfusion injury	External pressure exceeds capillary closing pressure (approximately 32 mmHg) → tissue ischemia; Pressure release → reperfusion injury with free radical generation; Repeated cycles lead to cumulative tissue damage
Malnutrition	Deficiency of substrates required for tissue repair	Protein deficiency → inadequate collagen synthesis; Vitamin C deficiency → impaired hydroxylation of proline and lysine in collagen; Zinc deficiency → impaired DNA synthesis and cell proliferation; Overall catabolic state diverts resources from wound healing
Infection and Biofilm	Persistent inflammation and tissue destruction	Bacterial biofilms are communities of bacteria encased in extracellular polymeric substance → protected from host immune response and antibiotics → perpetuate chronic inflammation → elevated MMPs → degradation of growth factors and extracellular matrix

Key Growth Factors in Wound Healing

Platelet-Derived Growth Factor (PDGF)

Source: Platelets, macrophages, fibroblasts

Function: Chemotaxis for neutrophils, macrophages, and fibroblasts; stimulates fibroblast proliferation and collagen synthesis

Clinical relevance: Recombinant PDGF (becaplermin) is the only FDA-approved growth factor for diabetic foot ulcers

Vascular Endothelial Growth Factor (VEGF)

Source: Macrophages, keratinocytes, fibroblasts

Function: Critical for angiogenesis; increases vascular permeability; stimulates endothelial cell proliferation and migration

Clinical relevance: Hypoxia is a potent stimulus for VEGF; chronic ischemia may exhaust this response

Transforming Growth Factor-Beta (TGF-β)

Source: Platelets, macrophages, fibroblasts, keratinocytes

Function: Regulates inflammation, stimulates fibroblast collagen synthesis, promotes wound contraction

Clinical relevance: Excess TGF-β associated with hypertrophic scarring and keloid formation

Local and Systemic Factors Affecting Wound Healing

Local Factors

Infection: Bacterial load greater than 10⁵ organisms per gram of tissue impairs healing
Tissue hypoxia: Oxygen tension less than 40 mmHg impairs collagen synthesis and neutrophil killing
Foreign bodies: Perpetuate inflammation and serve as nidus for infection
Necrotic tissue: Physical barrier to epithelialization; promotes bacterial growth
Repeated trauma: Continuous tissue damage prevents progression through healing phases
Venous congestion: Edema increases diffusion distance for oxygen and nutrients
Wound desiccation: Dry wounds heal more slowly than moist wounds

Systemic Factors

Age: Reduced inflammatory response, slower epithelialization, decreased collagen synthesis
Diabetes mellitus: Impaired neutrophil function, microangiopathy, neuropathy
Malnutrition: Protein, vitamin C, vitamin A, zinc, and iron deficiencies
Immunosuppression: Chemotherapy, corticosteroids, immunodeficiency states
Medications: Corticosteroids, NSAIDs, anticoagulants, some chemotherapeutic agents
Smoking: Vasoconstriction, carboxyhemoglobin, impaired neutrophil function
Chronic diseases: Renal failure, liver disease, heart failure (tissue edema)

The Role of Biofilm in Chronic Wounds

Biofilm: The Hidden Enemy

Biofilms are present in approximately 60 to 90% of chronic wounds compared to only 6% of acute wounds. Key characteristics include:

Structure: Organized bacterial communities encased in self-produced extracellular polymeric substance (EPS)
Protection: EPS provides physical and chemical barrier against antibiotics (up to 1000-fold increased resistance) and host immune cells
Persistence: Bacteria in biofilms exist in a dormant, low-metabolic state resistant to antibiotics that target actively dividing cells
Clinical clues: Excessive slough despite debridement, failure to respond to appropriate antibiotics, wound bed that looks “unhealthy” despite no obvious infection
Management: Requires physical disruption through debridement combined with topical antimicrobials; systemic antibiotics alone are ineffective

Often Overlooked: The Oxygen-Healing Connection

Oxygen is not merely important—it is essential for wound healing. Collagen synthesis requires oxygen for the hydroxylation of proline and lysine residues. Neutrophils require oxygen to generate the respiratory burst that kills bacteria. Angiogenesis is stimulated by hypoxia-inducible factors but requires adequate oxygen for new vessel formation. This explains why arterial ulcers are so difficult to heal without revascularization, and why patients who smoke (carboxyhemoglobin reduces oxygen delivery) have significantly impaired wound healing. Tissue oxygen tension, not just arterial oxygen saturation, determines healing capacity.

The MMP-TIMP Imbalance

Component	Normal Function	In Chronic Wounds	Clinical Consequence
Matrix Metalloproteinases (MMPs)	Controlled degradation of extracellular matrix to allow cell migration; removal of damaged tissue	Markedly elevated (up to 100-fold higher than acute wounds)	Excessive degradation of extracellular matrix; destruction of growth factors before they can act; perpetuation of tissue breakdown
Tissue Inhibitors of Metalloproteinases (TIMPs)	Regulate MMP activity; maintain balance between matrix synthesis and degradation	Reduced levels relative to MMPs	Loss of regulatory control; unopposed MMP activity; cannot shift from catabolic to anabolic state
Growth Factors (PDGF, VEGF, TGF-β)	Stimulate cell proliferation, migration, and matrix synthesis	Degraded by elevated MMPs; reduced bioavailability	Despite adequate production, growth factors are destroyed before they can promote healing

3. History Taking

A comprehensive approach to eliciting the non-healing wound history

Red Flags — Require Urgent Evaluation

Rapidly enlarging wound — Consider necrotizing fasciitis, malignancy, pyoderma gangrenosum
Severe pain disproportionate to appearance — Ischemia, necrotizing infection, calciphylaxis
Systemic signs (fever, rigors, confusion) — Sepsis from wound infection
Crepitus around wound — Gas gangrene, necrotizing fasciitis

Exposed bone, tendon, or joint — Osteomyelitis risk, urgent surgical consultation
New wound in immunocompromised patient — Atypical infections, accelerated progression
Rolled, heaped, or everted wound edges — Suspect malignancy (squamous cell carcinoma, Marjolin ulcer)
Rest pain or night pain in limb — Critical limb ischemia requiring urgent vascular assessment

Systematic History: The “WOUNDS” Approach

Use the mnemonic “WOUNDS” to ensure comprehensive history taking for any non-healing ulcer:

W — Wound characteristics: When did it start? How did it begin (spontaneous vs trauma)? Has it changed in size? What treatments have been tried?
O — Other symptoms: Pain (character, severity, timing)? Drainage? Odor? Surrounding skin changes? Systemic symptoms (fever, malaise)?
U — Underlying conditions: Diabetes? Peripheral vascular disease? Venous insufficiency? Autoimmune disease? Previous wounds or amputations?
N — Nutrition and habits: Dietary intake? Albumin levels? Smoking? Alcohol? Mobility and activity level?
D — Drugs and treatments: Current medications (especially steroids, immunosuppressants, anticoagulants)? Previous wound treatments? Allergies to dressings or topicals?
S — Social factors: Living situation? Caregiver support? Ability to perform dressing changes? Access to healthcare? Footwear (for foot ulcers)?

Detailed Wound History

Question Category	Key Questions to Ask	Why It Matters
Onset and Duration	“When did you first notice the wound?” “Did it start after an injury, or did it appear spontaneously?”	Spontaneous onset suggests vascular or metabolic etiology; traumatic onset with prolonged healing suggests impaired repair mechanisms
Progression	“Is the wound getting bigger, smaller, or staying the same?” “How quickly has it changed?”	Rapid enlargement suggests aggressive pathology (infection, malignancy, vasculitis); static wounds may have reached equilibrium but need etiology addressed
Pain Characteristics	“How would you describe the pain?” “Is it worse at rest, when walking, or when the leg is elevated?”	Rest pain and pain relieved by dependency suggests arterial disease; pain relieved by elevation suggests venous disease; painless wounds in diabetics suggest neuropathy
Discharge	“Is there any drainage from the wound?” “What color is it?” “Is there an odor?”	Purulent or foul-smelling discharge suggests infection; serous drainage is normal in healing wounds; excessive clear drainage may indicate venous congestion
Previous Treatments	“What treatments have been tried?” “Did anything help or make it worse?”	Determines what has failed; pathergy (worsening after debridement) suggests pyoderma gangrenosum; failure of compression suggests arterial component
Previous Episodes	“Have you had wounds like this before?” “Where were they?” “How were they treated?”	Recurrent wounds suggest ongoing underlying condition not addressed; history of amputation significantly increases risk

Targeted Questions by Suspected Cause

Suspected Cause	Key Features to Elicit	Ask This Question
Venous Insufficiency	Leg swelling, varicose veins, history of deep vein thrombosis, prolonged standing	“Does your leg swell during the day and improve overnight?” “Do you have varicose veins?” “Have you ever had a blood clot in your leg?”
Peripheral Arterial Disease	Claudication, rest pain, smoking history, diabetes, cardiovascular disease	“Do you get cramping in your calves when walking that goes away with rest?” “Do you have pain in your feet at night that makes you hang your leg over the bed?”
Diabetic Foot Ulcer	Diabetes duration, glycemic control, neuropathy symptoms, foot deformity, prior ulcers or amputation	“Do you have numbness, tingling, or burning in your feet?” “Can you feel it when you step on something sharp?” “What footwear do you typically use?”
Pressure Injury	Immobility, incontinence, malnutrition, cognitive impairment, recent hospitalization	“How much time do you spend in bed or in a chair?” “Can you reposition yourself?” “Do you have any problems with bladder or bowel control?”
Malignancy (Marjolin Ulcer)	Long-standing wound (often years), recent change in character, raised or rolled edges	“How long have you had this wound?” “Has it recently changed in appearance—become raised, started bleeding more, or developed a different texture?”
Pyoderma Gangrenosum	Inflammatory bowel disease, rheumatoid arthritis, pathergy, violaceous undermined borders	“Do you have any bowel problems like Crohn’s disease or ulcerative colitis?” “Did the wound get worse after any procedures or debridement?” “Do you have arthritis?”
Vasculitis	Multiple lesions, systemic symptoms, autoimmune history, palpable purpura	“Do you have any rashes elsewhere on your body?” “Have you had joint pain, kidney problems, or unexplained fevers?” “Are you taking any new medications?”

Pain Assessment in Chronic Wounds

Pain as a Diagnostic Clue

The character and timing of wound-related pain provides important diagnostic information:

Arterial ulcers: Severe pain, worse at night, relieved by dependency (hanging leg over bed), often requiring opioids
Venous ulcers: Aching, heaviness, relieved by elevation, often described as mild to moderate
Diabetic neuropathic ulcers: Often painless despite significant tissue damage (this is a red flag for unrecognized injury)
Infected wounds: Increasing pain suggests developing infection, even before other signs appear
Pyoderma gangrenosum: Intense pain out of proportion to wound size
Calciphylaxis: Excruciating pain in subcutaneous nodules progressing to ulceration

Medication and Social History

Medications That Impair Wound Healing

Corticosteroids: Suppress inflammation (required for healing initiation), reduce collagen synthesis, impair epithelialization
Immunosuppressants: Tacrolimus, cyclosporine, mycophenolate — impair immune function and tissue repair
Chemotherapeutic agents: Inhibit cell proliferation required for wound repair
NSAIDs: May impair early inflammatory phase; clinical significance debated but consider in refractory wounds
Anticoagulants: May cause wound hematomas; warfarin associated with calciphylaxis risk
Vasoconstrictors: Ergotamines, high-dose vasopressors reduce tissue perfusion
Hydroxycarbamide (hydroxyurea): Known to cause leg ulcers that heal when drug is stopped

Social and Occupational History

Smoking: Vasoconstriction, carboxyhemoglobin (reduces oxygen delivery), impairs neutrophil function — quantify pack-years and current status
Occupation: Prolonged standing (venous disease), occupational exposures (chemical burns, trauma risk), inability to offload foot
Living situation: Ability to perform wound care, keep wound clean, access to running water and supplies
Mobility: Ability to ambulate (calf muscle pump for venous return), risk of pressure injury if immobile
Nutrition: Food security, ability to prepare meals, recent weight loss
Support system: Caregiver availability, ability to attend appointments, transportation
Footwear: For diabetic foot ulcers — type of shoes worn, use of prescribed orthotics

Critical Past Medical History

Condition	Relevance to Wound Healing	Specific Questions
Diabetes Mellitus	Neuropathy, microangiopathy, immune dysfunction, delayed healing	Duration? HbA1c level? History of retinopathy, nephropathy, neuropathy? Previous foot ulcers or amputations?
Peripheral Vascular Disease	Reduced tissue perfusion essential for healing	Previous angioplasty or bypass surgery? Claudication distance? Rest pain?
Chronic Venous Insufficiency	Venous hypertension, skin changes, recurrent ulceration	History of deep vein thrombosis? Varicose veins? Previous venous procedures?
Autoimmune Diseases	Associated with vasculitis, pyoderma gangrenosum, atypical ulcers	Rheumatoid arthritis? Lupus? Inflammatory bowel disease? Antiphospholipid syndrome?
Chronic Kidney Disease	Uremia impairs healing; risk of calciphylaxis	On dialysis? Calcium and phosphate levels? History of hyperparathyroidism?
Malignancy	Immunosuppression from disease and treatment; risk of Marjolin ulcer in chronic wounds	Active cancer? Receiving chemotherapy or radiation? History of skin cancer?
Hematologic Disorders	Sickle cell disease causes leg ulcers; bleeding disorders affect hemostasis	Sickle cell disease? Blood clotting disorders? Taking blood thinners?

4. Physical Examination

A systematic approach to examining the patient with a non-healing wound

Systematic Framework: Use the “Three Zones” approach — examine the wound itself, the peri-wound area (surrounding 4-5 cm), and the whole patient (regional and systemic examination). Remember that the wound is a symptom of underlying disease, not just a local problem.

General Inspection

General appearance: Nutritional status (cachexia, obesity), mobility, mental status, signs of chronic illness
Skin: Pallor (anemia), jaundice (liver disease), uremic frost (renal failure), other ulcers or skin lesions
Edema: Generalized (cardiac, renal, hepatic) or localized (venous, lymphatic)
Mobility: Ambulatory status, use of wheelchair or bed-bound (pressure injury risk)
Self-care ability: Can patient see and reach the wound? Cognitive ability for wound care?

Vital Signs

Vital Sign	What to Look For	Clinical Significance
Temperature	Fever (greater than 38°C) or hypothermia	Fever suggests wound infection or sepsis; hypothermia may indicate severe sepsis in elderly or immunocompromised
Heart Rate	Tachycardia (greater than 100 bpm)	May indicate infection, pain, anemia, or hypovolemia from wound fluid losses
Blood Pressure	Hypertension or hypotension	Hypotension suggests sepsis; hypertension is cardiovascular risk factor associated with arterial disease
Respiratory Rate	Tachypnea (greater than 20 breaths per minute)	May indicate metabolic acidosis from sepsis or severe tissue necrosis
Oxygen Saturation	Hypoxia (less than 94% on room air)	Systemic hypoxia impairs wound healing; may indicate underlying cardiopulmonary disease
Blood Glucose	Hyperglycemia (greater than 180 mg/dL or 10 mmol/L)	Uncontrolled diabetes impairs wound healing and increases infection risk

Wound Examination: The “MEASURE” Framework

Systematic Wound Assessment

Use MEASURE to document wound characteristics at every visit:

M — Measure: Length × width × depth in centimeters; document undermining and tunneling (clock-face notation)
E — Exudate: Amount (none, scant, moderate, copious), type (serous, sanguineous, serosanguineous, purulent), odor
A — Appearance: Wound bed tissue type and percentage (necrotic/eschar, slough, granulation, epithelializing)
S — Suffering: Pain level (0-10 scale), pain timing (constant, with dressing changes, at night)
U — Undermining: Probe edges for pockets extending under intact skin; document location and depth
R — Re-evaluate: Compare to previous assessments; is the wound improving, stable, or deteriorating?
E — Edge: Wound margins — flat and attached, rolled, undermined, hyperkeratotic, macerated

Interpreting Wound Bed Appearance

Tissue Type	Visual Appearance	Clinical Interpretation	Management Implication
Black (Eschar)	Dry, hard, leathery, firmly attached	Full-thickness necrotic tissue; cannot assess depth beneath	Usually requires debridement; stable heel eschar may be exception
Yellow (Slough)	Soft, moist, stringy, yellow or tan	Dead cells, fibrin, and debris; may harbor bacteria	Debridement (sharp, enzymatic, autolytic, mechanical) promotes healing
Red (Granulation)	Beefy red, moist, granular, bleeds easily	Healthy healing tissue with new blood vessels and fibroblasts	Protect from trauma; maintain moist environment
Pink (Epithelializing)	Pale pink, silvery, new skin from edges or islands	Final phase of healing; fragile new epithelium	Protect from desiccation and mechanical trauma
Dark Red / Dusky	Dark, friable, excessive, or pale granulation	Unhealthy tissue — may indicate ischemia, infection, or biofilm	Investigate for infection, reassess perfusion, consider debridement
Green	Green discoloration with sweet or fruity odor	Pseudomonas aeruginosa colonization or infection	Topical antimicrobials; systemic antibiotics if cellulitis present

Wound Edge Characteristics

Edge Appearance	Description	Suggests
Attached and flat	Wound edges level with wound bed, epithelium advancing	Normal healing progression
Rolled (epibole)	Edges curled down and under, epithelium migrating down into wound	Stalled healing; may require debridement of wound edges
Undermined	Edges extend over wound bed with space beneath intact skin	Shearing injury, pressure injury, infection
Punched-out	Sharp, vertical, well-demarcated edges	Arterial ulcer, vasculitis, pyoderma gangrenosum
Raised or heaped	Elevated, irregular, often with fungating tissue	Malignancy (squamous cell carcinoma, Marjolin ulcer)
Violaceous or purple	Purple-blue discoloration of surrounding skin	Pyoderma gangrenosum, vasculitis, venous disease
Hyperkeratotic	Thickened, callused rim around wound	Diabetic foot ulcer (callus from abnormal pressure)
Macerated	White, soggy, fragile tissue around edges	Excessive moisture from wound exudate or inappropriate dressing

Peri-wound and Regional Examination

Peri-wound Skin (4-5 cm around wound)

Erythema: Cellulitis if spreading, warm, tender; normal inflammatory rim if localized (<2 cm) and non-tender
Induration: Hard, woody texture suggests deep infection or lipodermatosclerosis
Warmth: Compare to contralateral limb; warmth suggests infection or inflammation
Edema: Pitting edema (venous, cardiac); non-pitting (lymphedema, lipodermatosclerosis)
Hemosiderin staining: Brown discoloration from extravasated red blood cells — classic for venous disease
Lipodermatosclerosis: Hardened, indurated skin with “inverted champagne bottle” appearance — advanced venous disease
Atrophie blanche: White, atrophic plaques with telangiectasias — associated with venous disease and vasculitis

Regional Examination

Varicose veins: Visible, tortuous superficial veins — venous insufficiency
Limb shape: “Inverted champagne bottle” leg in chronic venous disease; muscle wasting in arterial disease
Hair distribution: Hair loss on lower leg and foot suggests arterial insufficiency
Nail changes: Thickened, dystrophic nails (onychomycosis, arterial disease, trauma)
Foot deformity: Charcot foot, claw toes, hallux valgus — altered pressure distribution in diabetic patients
Lymphadenopathy: Regional lymph nodes — may indicate infection or malignancy
Contralateral limb: Compare for symmetry; check for ulcers on other limb

Vascular Examination

Assessment	Technique	Findings and Interpretation
Pulse Palpation	Palpate femoral, popliteal, dorsalis pedis, and posterior tibial pulses	Absent or diminished pulses suggest peripheral arterial disease; document as present, diminished, or absent
Capillary Refill	Press on toe pulp for 3 seconds, release, time return of color	Normal: less than 3 seconds; prolonged refill suggests arterial insufficiency (though non-specific)
Ankle-Brachial Index (ABI)	Ratio of ankle systolic pressure to brachial systolic pressure using Doppler	Normal: 0.9-1.3; 0.5-0.9: claudication range; <0.5: rest pain likely; <0.4: tissue loss likely; >1.3: calcified vessels (unreliable)
Elevation Test	Elevate leg to 60° for 1 minute, observe for pallor	Pallor on elevation with dependent rubor on lowering (Buerger’s test) suggests severe arterial disease
Venous Filling Time	With leg elevated, veins should empty; on standing, note time to refill	Rapid refilling (<20 seconds) suggests venous insufficiency with valve incompetence
Trendelenburg Test	Elevate leg to empty veins, apply tourniquet, stand patient, release tourniquet	Rapid filling from above after tourniquet release indicates saphenofemoral junction incompetence

Neurological Examination (Especially for Diabetic Foot)

Modality	Test	Technique	Interpretation
Light Touch / Pressure	10-gram Semmes-Weinstein monofilament	Apply perpendicular to skin at multiple sites on sole until filament bends; ask patient if they feel it	Inability to detect at any site indicates loss of protective sensation and high ulcer risk
Vibration	128 Hz tuning fork	Place on bony prominence (great toe, medial malleolus); ask when vibration stops	Compare to examiner’s perception or proximal site; diminished vibration sense is early sign of neuropathy
Proprioception	Joint position sense	Hold sides of great toe, move up or down; ask patient to identify direction with eyes closed	Impaired proprioception contributes to abnormal gait and pressure distribution
Reflexes	Ankle reflex	Tap Achilles tendon with patient kneeling or with ankle dorsiflexed	Absent ankle reflex is common in diabetic neuropathy; compare sides
Pain	Pinprick	Compare sharp versus dull sensation in stocking distribution	Loss of pain sensation indicates significant neuropathy and ulcer risk

Special Tests

Probe-to-Bone Test for Osteomyelitis

For any deep ulcer, especially diabetic foot ulcers, perform the probe-to-bone test:

Technique: Using a sterile blunt metal probe, gently explore the wound base
Positive result: If hard, gritty bone is felt without intervening soft tissue
Interpretation: Positive test has high specificity (85-90%) for osteomyelitis in diabetic foot ulcers
Caveat: A negative test does not rule out osteomyelitis (sensitivity approximately 60%)
Clinical rule: “If you can see bone or probe to bone, osteomyelitis is present until proven otherwise”

Expected Findings by Etiology

Condition	Typical Location	Wound Appearance	Peri-wound/Regional Findings
Venous Ulcer	Medial lower leg (gaiter area), above medial malleolus	Shallow, irregular borders, moderate exudate, granulating or slough base	Edema, hemosiderin staining, lipodermatosclerosis, varicose veins, atrophie blanche
Arterial Ulcer	Toes, heel, lateral malleolus, pressure points	Deep, punched-out, pale or necrotic base, minimal exudate, well-demarcated	Absent pulses, pallor on elevation, dependent rubor, hair loss, cool limb, muscle wasting
Diabetic Foot Ulcer	Plantar surface under metatarsal heads, toes, heel	Variable depth, surrounded by callus, often painless, may have exposed bone	Loss of sensation to monofilament, foot deformity, claw toes, Charcot foot, dry cracked skin
Pressure Ulcer	Over bony prominences: sacrum, heels, ischium, greater trochanter	Variable by stage; may have undermining and tunneling	Limited mobility, incontinence, malnutrition, contractures
Pyoderma Gangrenosum	Lower legs most common; can occur anywhere, including surgical sites	Rapidly enlarging with violaceous undermined borders, necrotic base	History of pathergy, may have pustules at periphery, systemic disease (IBD, arthritis)
Malignant Ulcer	Any location, especially chronic wound sites	Raised, rolled, or everted edges; friable tissue; excessive granulation	Long-standing wound (>10 years for Marjolin), recent change in character, failure to respond to treatment

Important Teaching Point: Don’t Forget the Complete Examination

While focus naturally centers on the wound, a complete systemic examination is essential. Consider:

Cardiovascular: Atrial fibrillation (embolic disease), murmurs (endocarditis), edema (heart failure)
Abdominal: Hepatomegaly (liver disease, malnutrition), abdominal aortic aneurysm (arterial disease), organomegaly
Fundoscopy: Diabetic retinopathy correlates with microvascular disease elsewhere
Other skin sites: Additional ulcers, rashes (vasculitis), signs of self-harm
Nutritional assessment: Temporal wasting, loss of subcutaneous fat, muscle bulk

Up to 20% of lower extremity ulcers have mixed etiology (especially combined arterial and venous disease), requiring comprehensive assessment to address all contributing factors.

5. Differential Diagnosis

Systematic approach organized by probability, etiology, and clinical features

The differential diagnosis of non-healing wounds is broad, but a systematic approach based on probability and clinical features allows efficient narrowing of the possibilities. The vast majority of chronic lower extremity ulcers fall into four major categories (venous, arterial, diabetic neuropathic, and pressure), but it is essential to recognize atypical presentations that suggest less common but important diagnoses.

Step-by-Step Approach to Differential Diagnosis:

Step 1: Establish the wound is truly “chronic” (greater than 4-6 weeks without healing progress)
Step 2: Identify the anatomical location — this strongly suggests etiology
Step 3: Look for the “Big Four” common causes — venous, arterial, diabetic, pressure
Step 4: If atypical features present, consider less common causes (malignancy, vasculitis, infection, inflammatory)
Step 5: Remember that 15-20% of wounds have mixed etiology — don’t stop at the first diagnosis

Lower Extremity Ulcers: Differential by Probability

Probability	Condition	Key Distinguishing Features	Red Flags for This Diagnosis
COMMON (approximately 70%)	Chronic Venous Insufficiency	Medial lower leg location, shallow, irregular borders, surrounding hemosiderin staining, edema that worsens with standing	Rapid deterioration suggests superimposed arterial disease or infection
COMMON (approximately 15-25% of diabetics)	Diabetic Foot Ulcer	Plantar surface or pressure points, painless, surrounded by callus, foot deformity, loss of protective sensation	Exposed bone, rapidly spreading erythema, systemic symptoms suggest osteomyelitis or necrotizing infection
LESS COMMON (approximately 10-15%)	Peripheral Arterial Disease	Distal location (toes, heel, lateral malleolus), punched-out, painful, pale base, absent pulses, rest pain	Rapid progression to gangrene indicates critical limb ischemia — urgent vascular referral
LESS COMMON (approximately 5-10%)	Pressure Injury	Over bony prominences, in immobile patients, may have undermining, staging from I to IV	Exposed bone, foul odor, purulent drainage suggest deep infection or osteomyelitis
LESS COMMON	Mixed Arteriovenous Ulcer	Features of both venous and arterial disease, ABI between 0.5-0.8, modified compression required	Standard compression in presence of arterial disease can cause limb-threatening ischemia
UNCOMMON BUT SERIOUS (approximately 2-5%)	Malignancy (Squamous Cell Carcinoma / Marjolin Ulcer)	Long-standing wound (often years) with recent change, raised or rolled edges, excessive friable tissue, failure to respond to treatment	Any chronic wound greater than 10 years duration, or wound with atypical appearance should have biopsy
UNCOMMON BUT SERIOUS	Pyoderma Gangrenosum	Rapidly enlarging, violaceous undermined borders, pathergy (worsening after debridement), associated inflammatory bowel disease or arthritis	Debridement worsens the wound — recognize before surgery; requires immunosuppression, not surgery
UNCOMMON BUT SERIOUS	Vasculitis	Multiple lesions, palpable purpura, livedo reticularis, systemic symptoms, associated autoimmune disease	May indicate systemic disease affecting kidneys, lungs, nerves — requires systemic evaluation

Anatomical Approach: Location Suggests Etiology

Medial Lower Leg (Gaiter Area)

Venous insufficiency (most common)

Mixed arteriovenous disease

Vasculitis

Pyoderma gangrenosum

Lateral Lower Leg / Malleolus

Arterial insufficiency

Trauma

Vasculitis

Necrobiosis lipoidica (pretibial)

Plantar Foot / Toes

Diabetic neuropathic ulcer

Arterial insufficiency (toes, heel)

Foreign body

Malignant melanoma (subungual)

Bony Prominences

Pressure injury (sacrum, heels, ischium)

Arterial disease (heel, malleoli)

Diabetic neuropathy (metatarsal heads)

Osteomyelitis (any bony area)

When to Suspect an Atypical Cause

Features Suggesting Atypical Etiology — Consider Biopsy

Wound fails to improve after 4-6 weeks of appropriate treatment for presumed etiology
Atypical location (not in usual distribution for common causes)
Unusual wound bed appearance (exuberant granulation tissue, fungating, rapidly progressive)
Rolled, everted, or heaped wound edges
Pain disproportionate to wound appearance
Pathergy (wound worsens after debridement or trauma)
Multiple simultaneous ulcers in different locations
Associated systemic symptoms (fever, weight loss, joint pain, rash elsewhere)
History of immunosuppression, autoimmune disease, or malignancy
Long-standing wound (greater than 10 years) with recent change in character

Differential Diagnosis of Atypical Ulcers

Category	Conditions	Key Clinical Clues	Diagnostic Approach
Malignancy	Squamous cell carcinoma, basal cell carcinoma, Marjolin ulcer, melanoma, Kaposi sarcoma, cutaneous lymphoma	Raised or rolled edges, excessive tissue, bleeding, long-standing wound with change, failure to heal despite appropriate treatment	Punch or incisional biopsy from wound edge; multiple biopsies if large wound
Inflammatory	Pyoderma gangrenosum, necrobiosis lipoidica diabeticorum, sarcoidosis, calciphylaxis	Pathergy, violaceous borders (pyoderma gangrenosum), waxy yellow plaques (necrobiosis lipoidica), excruciating pain with retiform purpura (calciphylaxis)	Biopsy (but may be non-specific in pyoderma gangrenosum); clinical diagnosis often required; check calcium, phosphate, PTH for calciphylaxis
Vasculitis	Small vessel (leukocytoclastic), medium vessel (polyarteritis nodosa), large vessel, livedoid vasculopathy, antiphospholipid syndrome	Palpable purpura, livedo reticularis, multiple lesions, systemic symptoms, stellate pattern ulcers	Skin biopsy for vasculitis; ANA, ANCA, antiphospholipid antibodies, complement levels, cryoglobulins
Infectious	Atypical mycobacteria, deep fungal infection, ecthyma gangrenosum, cutaneous leishmaniasis, syphilitic gumma	Immunocompromised host, travel history, unusual appearance, sporotrichoid spread, failure to respond to standard antibiotics	Tissue culture for bacteria, mycobacteria, fungi; biopsy with special stains; PCR for specific organisms
Hematologic	Sickle cell disease, cryoglobulinemia, polycythemia vera, thrombocytosis	Known hematologic disorder, leg ulcers in young patient, cold-induced symptoms (cryoglobulinemia)	Complete blood count, hemoglobin electrophoresis, cryoglobulins, protein electrophoresis
Drug-Induced	Hydroxyurea, warfarin (calciphylaxis/necrosis), methotrexate, ergotamines	Temporal relationship to drug initiation, resolution after drug withdrawal	Medication review; trial of drug discontinuation; skin biopsy if uncertain
Factitial / Self-Inflicted	Dermatitis artefacta, malingering	Geometric or bizarre shape, accessible locations only, inconsistent history, psychological comorbidity	Careful history; observation; psychiatric evaluation; exclude organic causes first

Drug-Induced Non-Healing Ulcers

Drug	Mechanism	Clinical Characteristics	Time to Resolution After Stopping
Hydroxyurea (Hydroxycarbamide)	Direct toxicity to keratinocytes; inhibits DNA synthesis required for wound repair	Painful leg ulcers, often bilateral, near malleoli; occurs in patients on long-term therapy for myeloproliferative disorders	Weeks to months after discontinuation; some ulcers persist
Warfarin	Protein C and S depletion causing transient hypercoagulable state; also associated with calciphylaxis	Warfarin necrosis: painful erythema progressing to necrosis in fatty areas (breasts, buttocks, thighs) within days of initiation; Calciphylaxis: painful subcutaneous nodules progressing to ulceration	Warfarin necrosis requires immediate discontinuation and heparin; calciphylaxis requires multimodal management
Ergotamine / Ergot Alkaloids	Potent vasoconstriction causing tissue ischemia	Ischemic ulcers, often on extremities; may mimic arterial disease	Days to weeks after discontinuation; vasodilators may help
Nicorandil	Unknown mechanism; possibly related to nitric oxide pathway	Painful mucosal and skin ulcers; perianal ulcers common; oral ulcers	Resolution typically within weeks of stopping
Methotrexate	Antiproliferative effect; may cause mucocutaneous ulceration especially with toxicity	Oral and skin ulcers, particularly with high doses or renal impairment	Days to weeks; check for toxicity, folate supplementation
Corticosteroids (systemic, long-term)	Impair all phases of wound healing; reduce collagen synthesis; increase infection risk	Poor wound healing rather than causing ulcers directly; thin fragile skin prone to injury	Wound healing improves with dose reduction; cannot always stop

Special Considerations by Patient Population

Immunocompromised Patients

HIV/AIDS: Kaposi sarcoma, atypical mycobacterial infections, deep fungal infections, bacillary angiomatosis
Transplant recipients: Squamous cell carcinoma (increased risk), opportunistic infections
Chemotherapy patients: Neutropenic infections, poor healing from antiproliferative effects
Biologic therapy: Reactivation of tuberculosis (check before anti-TNF therapy), atypical infections

Dialysis Patients

Calciphylaxis: Excruciatingly painful, retiform purpura progressing to necrotic ulcers; high mortality; check calcium, phosphate, PTH
Uremic vasculopathy: Impaired wound healing from uremia
Peripheral arterial disease: Highly prevalent in dialysis population
Steal syndrome: Ulcers distal to AV fistula from arterial steal

Quick Reference: “If You See This, Think This”

Clinical Clue	Think This First	Next Step
Medial lower leg + edema + hemosiderin staining	Venous insufficiency	Confirm with duplex ultrasound; check ABI to exclude arterial component; initiate compression if ABI normal
Toe or heel ulcer + absent pulses + rest pain	Peripheral arterial disease	Urgent ABI and arterial duplex; vascular surgery referral; revascularization assessment
Plantar ulcer + diabetic + callus rim + painless	Diabetic neuropathic ulcer	Probe-to-bone test; X-ray for osteomyelitis; offloading; assess for infection
Sacrum or heel + immobile patient	Pressure injury	Stage the wound; pressure redistribution; nutritional assessment; address incontinence
Violaceous undermined borders + worsens with debridement	Pyoderma gangrenosum	STOP debridement; biopsy edge for histology; screen for inflammatory bowel disease; immunosuppression (steroids, cyclosporine)
Long-standing ulcer + raised edges + recent change	Squamous cell carcinoma (Marjolin ulcer)	Multiple punch biopsies from wound edge; staging if positive; wide excision
Excruciating pain + dialysis patient + retiform purpura	Calciphylaxis	Check calcium × phosphate product; PTH level; stop warfarin if possible; sodium thiosulfate; wound care; high mortality
Multiple ulcers + palpable purpura + systemic symptoms	Vasculitis	Skin biopsy; autoimmune workup (ANA, ANCA, complement); assess for systemic involvement (renal, pulmonary)
Leg ulcer + hydroxyurea therapy	Hydroxyurea-induced ulcer	Discuss with hematology regarding drug cessation; ulcer should heal after stopping
Geometric shape + only accessible areas + psychiatric history	Factitial / self-inflicted	Non-judgmental approach; exclude organic causes first; psychiatric evaluation; observe under occlusion

6. Diagnostic Investigations

A stepwise, cost-effective approach guided by clinical suspicion

The investigation of non-healing wounds should be guided by clinical assessment. Not every patient requires every test. Begin with baseline investigations to assess healing capacity and exclude common underlying conditions, then proceed to targeted investigations based on the suspected etiology. The goal is to identify treatable causes of impaired healing while avoiding unnecessary testing.

Baseline Investigations for All Patients with Chronic Wounds

Investigation	Purpose	What to Look For	Practical Points
Complete Blood Count (CBC)	Assess for anemia, infection, hematologic disorders	Anemia (impairs oxygen delivery); leukocytosis (infection); thrombocytosis (myeloproliferative disorder); leukopenia (immunosuppression)	Hemoglobin less than 10 g/dL significantly impairs wound healing
Fasting Glucose and HbA1c	Screen for diabetes; assess glycemic control	Diabetes mellitus (fasting glucose ≥126 mg/dL or 7.0 mmol/L); HbA1c ≥6.5% diagnostic; HbA1c greater than 8% indicates poor control	Every patient with chronic lower extremity ulcer should be screened for diabetes
Renal Function (Creatinine, eGFR)	Assess kidney function; identify uremia	Chronic kidney disease impairs healing; uremia affects immune function; elevated creatinine — caution with contrast imaging	CKD patients at risk for calciphylaxis; metformin contraindication if severe CKD
Albumin and Pre-albumin	Assess nutritional status	Albumin less than 3.5 g/dL indicates malnutrition; pre-albumin reflects more recent nutritional status (half-life 2-3 days)	Serum albumin is single best predictor of surgical wound complications
C-Reactive Protein (CRP) or ESR	Assess for inflammation and infection	Elevated CRP suggests infection or inflammatory condition; useful for monitoring response to treatment	Non-specific but elevated levels should prompt search for infection source
Ankle-Brachial Index (ABI)	Assess arterial perfusion	Normal: 0.9-1.3; Less than 0.9: peripheral arterial disease; Less than 0.5: critical limb ischemia; Greater than 1.3: calcified vessels (unreliable)	Essential before initiating compression therapy for leg ulcers; compression contraindicated if ABI less than 0.5

Additional Baseline Tests to Consider

Investigation	When to Order	What to Look For
Liver Function Tests	Suspected liver disease, alcoholism, malnutrition, unexplained edema	Hypoalbuminemia, coagulopathy, hepatic dysfunction contributing to poor healing
Coagulation Studies (PT/INR, PTT)	Patients on anticoagulants, liver disease, bleeding wounds	Coagulopathy may cause wound hematomas; warfarin-induced calciphylaxis or skin necrosis
Vitamin Levels (C, D, B12, Folate)	Malnutrition suspected, elderly, restricted diet, alcoholism	Vitamin C essential for collagen synthesis; B12/folate for cell proliferation; Vitamin D deficiency common
Zinc Level	Malnutrition, malabsorption, wounds failing to epithelialize	Zinc essential for DNA synthesis and cell proliferation; deficiency impairs wound healing
Thyroid Function Tests	Signs of thyroid disease, unexplained delayed healing	Both hypothyroidism and hyperthyroidism can impair wound healing
Hemoglobin Electrophoresis	Young patient with leg ulcers, African or Mediterranean ancestry	Sickle cell disease or trait — leg ulcers are common complication of sickle cell disease

Targeted Investigations by Suspected Etiology

If Suspecting Venous Insufficiency

First-Line Tests

Ankle-Brachial Index: Must exclude significant arterial disease before compression (ABI should be greater than 0.8 for full compression, 0.5-0.8 for modified compression)
Venous Duplex Ultrasound: Identifies superficial and deep venous reflux, post-thrombotic changes, venous obstruction; quantifies reflux duration (greater than 0.5 seconds is abnormal)

Second-Line Tests

CT or MR Venography: If proximal venous obstruction suspected (iliac vein compression, May-Thurner syndrome)
Plethysmography: Assesses overall venous function; less commonly used now with availability of duplex

If Suspecting Arterial Insufficiency

First-Line Tests

Ankle-Brachial Index: Less than 0.9 indicates peripheral arterial disease; less than 0.5 suggests critical limb ischemia; greater than 1.3 suggests calcified vessels (unreliable — use toe pressures)
Toe-Brachial Index: Useful when ABI unreliable due to calcification (common in diabetes and renal failure); less than 0.7 abnormal; less than 0.3 suggests critical ischemia
Arterial Duplex Ultrasound: Non-invasive assessment of stenosis location and severity

Second-Line Tests

CT Angiography: Detailed anatomical assessment; planning for revascularization; requires contrast (caution in CKD)
MR Angiography: Alternative to CTA; no ionizing radiation; avoid gadolinium in severe CKD
Digital Subtraction Angiography: Gold standard; allows intervention at same time; invasive
Transcutaneous Oxygen Measurement (TcPO2): Measures tissue oxygenation; greater than 40 mmHg suggests adequate healing potential; less than 20 mmHg poor prognosis

If Suspecting Diabetic Foot Ulcer

First-Line Tests

Probe-to-Bone Test: Positive test has approximately 85% specificity for osteomyelitis
Plain X-ray of Foot: Look for osteomyelitis (cortical erosion, periosteal reaction, sequestrum), Charcot changes, soft tissue gas, foreign body
Wound Culture: Superficial swabs are unreliable; tissue culture from curettage or biopsy preferred; culture should be taken after wound bed preparation
ABI or Toe Pressures: Assess for concomitant arterial disease (common in diabetics)

Second-Line Tests (If Osteomyelitis Suspected)

MRI: Most sensitive and specific imaging for osteomyelitis (sensitivity 90%, specificity 80%); distinguishes soft tissue from bone infection
Bone Biopsy: Gold standard for diagnosis of osteomyelitis; obtain before starting antibiotics if possible; identifies causative organism
White Cell Scan (Leukocyte Scintigraphy): Alternative if MRI contraindicated; combined with bone scan improves specificity
ESR and CRP: ESR greater than 70 mm/hr strongly suggests osteomyelitis in diabetic foot infection

If Suspecting Atypical or Inflammatory Cause

Biopsy

Punch Biopsy (4mm): From wound edge including normal and abnormal tissue; for histopathology
Multiple Biopsies: For large wounds or suspected malignancy — sample different areas
Tissue for Culture: Separate specimen for bacterial, mycobacterial, and fungal culture if infection suspected
Direct Immunofluorescence: If vasculitis suspected — take from lesional and perilesional skin

Autoimmune and Vasculitis Workup

ANA: Screening for systemic lupus erythematosus, other connective tissue diseases
ANCA (p-ANCA, c-ANCA): Granulomatosis with polyangiitis, microscopic polyangiitis
Complement (C3, C4): Low in lupus, cryoglobulinemia
Cryoglobulins: Cryoglobulinemic vasculitis (hepatitis C associated)
Antiphospholipid Antibodies: Lupus anticoagulant, anticardiolipin, anti-β2 glycoprotein I
Hepatitis B and C Serology: Associated with vasculitis (polyarteritis nodosa, cryoglobulinemia)
Rheumatoid Factor: Rheumatoid vasculitis, cryoglobulinemia

If Suspecting Calciphylaxis

Calciphylaxis Investigation

Calciphylaxis (calcific uremic arteriolopathy) is a medical emergency with mortality rates of 60-80%. Key investigations:

Calcium and Phosphate: Calculate calcium × phosphate product (greater than 70 mg²/dL² is concerning)
Parathyroid Hormone (PTH): Both high and low levels associated with calciphylaxis
Vitamin D Levels: Both deficiency and excess can contribute
Skin Biopsy: Shows calcification of small dermal and subcutaneous vessels; may be non-diagnostic; biopsy itself can cause wound extension
Plain X-ray or Mammography: May show “pipe-stem” vascular calcification
Bone Scan: Increased uptake in soft tissues may be seen

Wound Cultures: When and How

Principles of Wound Culture

Indication: Clinical signs of infection (increasing pain, erythema, warmth, purulent discharge, fever, elevated inflammatory markers) — not routine for all chronic wounds
Surface swabs are unreliable: They sample colonizing organisms, not pathogens causing deep infection
Preferred technique: Clean wound first, then obtain tissue sample by curettage of wound base or punch biopsy
Quantitative culture: Greater than 10⁵ organisms per gram of tissue indicates infection (not just colonization)
Bone culture: Gold standard for osteomyelitis; should be obtained if bone involved
When to culture for atypical organisms: Immunocompromised patient, travel history, failure to respond to standard antibiotics — request mycobacterial and fungal cultures

Imaging Modalities Summary

Modality	Primary Indications	Advantages	Limitations
Plain X-ray	Diabetic foot (osteomyelitis, Charcot, foreign body, gas)	Inexpensive, widely available, no contrast needed	Low sensitivity for early osteomyelitis (30-50%); changes lag 10-21 days
Venous Duplex Ultrasound	Venous insufficiency — reflux, obstruction, DVT	Non-invasive, no radiation, can be repeated, shows flow dynamics	Operator dependent; limited visualization of iliac veins
Arterial Duplex Ultrasound	Peripheral arterial disease — stenosis location	Non-invasive, no contrast, identifies stenosis location	Operator dependent; limited by calcification and body habitus
CT Angiography	Arterial disease — planning revascularization	Detailed anatomical mapping, widely available, fast	Radiation exposure, contrast nephrotoxicity, calcification artifact
MRI	Osteomyelitis, soft tissue infection, deep abscess	Best for osteomyelitis (90% sensitivity), soft tissue detail, no radiation	Expensive, claustrophobia, contraindicated with some implants, gadolinium risk in CKD
Nuclear Medicine (Bone Scan, WBC Scan)	Osteomyelitis when MRI contraindicated	High sensitivity, can image entire body	Low specificity (bone scan); WBC scan more specific but technically demanding

Stepwise Investigation Algorithm

Practical Approach to Investigating Chronic Wounds:

All patients: CBC, glucose/HbA1c, renal function, albumin, ABI
Lower extremity ulcer: Add venous duplex if clinical features suggest venous disease; add arterial duplex if pulses absent or ABI abnormal
Diabetic foot ulcer: Add X-ray foot; if probe-to-bone positive or osteomyelitis suspected, add MRI and consider bone biopsy
Signs of infection: Tissue culture (not superficial swab); inflammatory markers (CRP, ESR)
Atypical features: Punch biopsy from wound edge; autoimmune workup if vasculitis suspected
Failure to respond to appropriate treatment after 6 weeks: Biopsy to exclude malignancy and other atypical causes

7. Pattern Recognition and Clinical Decision-Making

Practical algorithms and decision pathways for non-healing wounds

Step 1: Is This Urgent?

Clinical Scenario	Urgency Level	Immediate Action
Rapidly spreading erythema, crepitus, systemic toxicity	EMERGENT	Suspect necrotizing fasciitis — Emergency surgical consultation, IV antibiotics, resuscitation; mortality increases with each hour of delay
Rest pain, absent pulses, cold limb, acute onset	EMERGENT	Acute limb ischemia — Emergency vascular surgery; revascularization within 6 hours to save limb
Sepsis (fever, tachycardia, hypotension, confusion) from wound	EMERGENT	Sepsis protocol — Blood cultures, IV antibiotics, fluid resuscitation, source control (debridement)
Critical limb ischemia (rest pain, tissue loss, ABI less than 0.4)	URGENT	Urgent vascular surgery referral within 24-48 hours; limb at risk without revascularization
Diabetic foot infection with deep space involvement	URGENT	Hospital admission, IV antibiotics, imaging for abscess, surgical debridement often required
Suspected osteomyelitis (positive probe-to-bone, X-ray changes)	URGENT	MRI, bone biopsy before antibiotics if possible; prolonged antibiotic course; surgical debridement may be needed
Rapidly enlarging wound with violaceous borders (pyoderma gangrenosum)	URGENT	STOP any debridement; dermatology consultation; systemic immunosuppression (steroids, cyclosporine)
Chronic stable wound, no infection, adequate perfusion	ROUTINE	Systematic evaluation, address underlying etiology, optimize wound care, follow-up in 2-4 weeks

Step 2: Initial Assessment Framework

The “ABC” of Wound Assessment:

A — Arterial supply: Can this wound heal with current blood supply? Check pulses, ABI. If ABI less than 0.5 or absent pulses with tissue loss, revascularization is priority.
B — Bacterial burden: Is infection preventing healing? Look for clinical signs of infection (not just positive culture). Treat infection before advanced wound care.
C — Cause: What is the underlying etiology? Address the cause (compression for venous, offloading for diabetic, pressure relief for pressure ulcer) — dressings alone will not heal these wounds.

Step 3: Management Pathway by Etiology

Pathway A: Venous Leg Ulcer

Clinical Scenario	Key Decision Point	Action
Typical venous ulcer, ABI greater than 0.8	Adequate arterial supply confirmed	Full compression therapy (30-40 mmHg); appropriate wound dressing; leg elevation; treat infection if present
Venous features but ABI 0.5-0.8	Mixed arteriovenous disease	Modified (reduced) compression (20-30 mmHg); vascular surgery referral; may need revascularization before full compression
Venous ulcer with ABI less than 0.5	Significant arterial disease	NO compression until revascularization; urgent vascular referral; compression could cause limb-threatening ischemia
Venous ulcer not healing after 4-6 weeks of compression	Treatment failure	Reassess: Is compression being worn? Is there underlying arterial disease? Consider biopsy to exclude malignancy; consider venous intervention
Healed venous ulcer	Prevention of recurrence	Lifelong compression stockings (Class 2, 20-30 mmHg); leg elevation; skin care; treat varicose veins if present

Pathway B: Arterial Ulcer

Clinical Scenario	Key Decision Point	Action
Arterial ulcer with ABI 0.5-0.9	Claudication-range disease	Vascular surgery referral; may heal with conservative management and risk factor modification; revascularization if not healing
Arterial ulcer with ABI less than 0.5 or rest pain	Critical limb ischemia	Urgent vascular surgery; revascularization essential for healing; wound care secondary to perfusion
Arterial ulcer, patient not candidate for revascularization	Non-revascularizable disease	Comfort care; pain management; dry wound care; prevent infection; may need amputation if gangrene progresses
Post-revascularization wound not healing	Revascularization failure or other factors	Reassess perfusion (graft patency); look for other factors (infection, malnutrition); consider re-intervention

Pathway C: Diabetic Foot Ulcer

Clinical Scenario	Key Decision Point	Action
Neuropathic ulcer, no infection, adequate perfusion	Offloading is key	Total contact cast or irremovable walking boot; debride callus; appropriate dressing; optimize glycemic control
Diabetic foot infection (mild: local signs only)	Outpatient management possible	Oral antibiotics (2 weeks); wound care; offloading; close follow-up (48-72 hours)
Diabetic foot infection (moderate: cellulitis greater than 2 cm or deep)	Consider admission	IV antibiotics; imaging for abscess or osteomyelitis; surgical debridement if abscess; glycemic control
Diabetic foot infection (severe: systemic signs, sepsis)	Admission mandatory	IV antibiotics; urgent surgical debridement; ICU if septic; may require amputation
Diabetic foot ulcer with osteomyelitis	Bone involvement	Bone biopsy if possible; prolonged antibiotics (6 weeks IV or oral); surgical debridement of infected bone; may need amputation if extensive
Diabetic foot ulcer with peripheral arterial disease	Neuroischemic ulcer	Address both components; vascular referral for revascularization; offloading still important; higher amputation risk

Pathway D: Pressure Injury

Clinical Scenario	Key Decision Point	Action
Stage 1-2 pressure injury	Superficial damage	Pressure redistribution (specialty mattress, repositioning every 2 hours); protect skin; optimize nutrition; moist wound healing for Stage 2
Stage 3-4 pressure injury	Deep tissue damage	Pressure redistribution; debridement of necrotic tissue (except stable heel eschar); manage exudate; nutritional support; consider surgical closure
Unstageable pressure injury (eschar covering)	Depth unknown	If infected or fluctuant: urgent debridement; if stable, dry heel eschar: do NOT debride (protective); otherwise, debride to stage
Pressure injury with suspected osteomyelitis	Bone involvement	MRI or bone biopsy; prolonged antibiotics; surgical debridement; may require flap reconstruction
Recurrent pressure injury in same location	Inadequate pressure relief	Review pressure redistribution; assess for bony prominence requiring surgical reduction; evaluate patient turning and mobility

“What Do I Do If…” Decision Reference

Clinical Situation	Immediate Action	Referral / Next Step
Wound not improving after 4-6 weeks of appropriate treatment	Reassess diagnosis and contributing factors	Biopsy to exclude malignancy; specialist wound care referral; consider advanced therapies
Wound getting worse despite treatment	Stop current treatment; complete reassessment	Consider pyoderma gangrenosum (stop debridement); biopsy; dermatology referral if inflammatory cause suspected
Exposed bone or tendon	Keep moist; prevent desiccation	Surgical consultation for coverage (flap, graft); if diabetic foot, assess for osteomyelitis
Suspected malignancy (raised edges, exuberant tissue)	Multiple punch biopsies from wound edge	If positive: oncology referral, wide excision planning, staging workup
Patient cannot perform wound care or attend appointments	Assess social situation and support	Home nursing referral; social work involvement; family education; consider admission if wound deteriorating
Wound healed — now what?	Address ongoing risk factors	Secondary prevention: compression stockings for venous, protective footwear for diabetic, pressure redistribution for immobile

Wound Bed Preparation: The TIME Framework

Systematic Approach to Local Wound Care

Use the TIME framework to optimize the wound bed for healing:

T — Tissue: Is there non-viable tissue? Remove necrotic tissue and slough through debridement (sharp, enzymatic, autolytic, mechanical, or biological)
I — Infection/Inflammation: Is infection or excessive inflammation present? Treat with topical antimicrobials for localized infection; systemic antibiotics for spreading infection or systemic signs
M — Moisture: Is moisture balanced? Too wet causes maceration (use absorbent dressings); too dry impairs cell migration (use moisture-donating dressings)
E — Edge: Are wound edges advancing? Non-advancing edges may need debridement of rolled edges; assess for underlying factors preventing closure

Troubleshooting the Non-Healing Wound

When the Wound Isn’t Healing — Ask These Questions

Is the diagnosis correct? Re-evaluate etiology; consider biopsy if atypical features or not responding
Is the underlying cause being addressed? Compression for venous? Offloading for diabetic? Pressure relief for pressure injury? Revascularization for arterial?
Is there uncontrolled infection? Look for subtle signs; consider biofilm; tissue culture if not responding to antibiotics
Is there adequate arterial supply? Re-check ABI; consider angiography if perfusion uncertain
Are there multiple contributing factors? 15-20% of wounds have mixed etiology; address all components
Is there an unrecognized systemic factor? Malnutrition, uncontrolled diabetes, immunosuppression, medications
Is the patient adhering to treatment? Wearing compression? Using offloading device? Attending dressing changes?
Could this be malignancy? Any wound not responding after 6 weeks should be biopsied

8. Clinical Pearls and Pitfalls

Practical wisdom — learn from successes and avoid common mistakes

Must-Know Clinical Pearls

Address the cause, not just the wound: No dressing will heal a venous ulcer without compression, a diabetic ulcer without offloading, or an arterial ulcer without revascularization. Treatment of the underlying etiology is always the priority.

Always check the ABI before compression: Compression therapy for venous ulcers can cause limb-threatening ischemia if significant arterial disease is present. An ABI greater than 0.8 is required for full compression; 0.5-0.8 requires modified compression; less than 0.5 is a contraindication.

A painless foot ulcer is not a benign ulcer: Loss of protective sensation in diabetic neuropathy means patients cannot feel tissue damage. Painless ulcers can progress to limb-threatening infection and amputation. Take them seriously.

Probe-to-bone positive = osteomyelitis until proven otherwise: In diabetic foot ulcers, if you can feel bone with a metal probe, the specificity for osteomyelitis is approximately 85%. Assume bone involvement and investigate accordingly.

Biopsy any wound not healing after 6 weeks of appropriate treatment: Non-healing wounds can harbor squamous cell carcinoma (Marjolin ulcer). A simple punch biopsy from the wound edge can be diagnostic and potentially life-saving.

Think mixed etiology: Up to 20% of chronic lower extremity wounds have multiple contributing factors (commonly combined arterial and venous disease). Finding one diagnosis doesn’t mean you’ve found the only diagnosis.

Stable heel eschar should NOT be debrided: Dry, stable eschar on the heel without signs of infection acts as a biological dressing. Debridement exposes underlying tissue to infection and may result in a wound that cannot heal without surgery.

Serum albumin less than 3.5 g/dL predicts poor wound healing: Nutritional status is one of the most important modifiable factors in wound healing. Optimize protein intake and address malnutrition as part of wound management.

Critical Pitfalls to Avoid

Applying compression without checking arterial supply: This is a potentially limb-threatening error. Full compression in a patient with an ABI less than 0.5 can cause critical ischemia and tissue necrosis. Always check the ABI first.

Debriding a wound that worsens with debridement: If a wound enlarges after debridement, consider pyoderma gangrenosum (pathergy). Stop debridement immediately and refer to dermatology. Continued debridement makes pyoderma gangrenosum worse.

Relying on surface swabs for wound culture: Surface swabs grow colonizing organisms, not necessarily the pathogens causing deep tissue infection. Use tissue culture from curettage or biopsy for reliable results.

Treating all chronic wounds the same way: Different etiologies require completely different management. Venous ulcers need compression; diabetic ulcers need offloading; arterial ulcers need revascularization. One approach does not fit all.

Missing malignancy in long-standing wounds: Any wound present for more than 10 years (especially burn scars) is at risk for squamous cell carcinoma (Marjolin ulcer). Any wound with raised or rolled edges should be biopsied.

Ignoring medication history: Hydroxyurea is a well-known but often forgotten cause of leg ulcers. Always review medications — several drugs can cause or contribute to non-healing wounds.

Stopping secondary prevention after healing: Chronic wounds have high recurrence rates (up to 70% for venous ulcers without ongoing compression). Lifelong preventive measures are essential after healing.

Underestimating diabetic foot infections: What appears to be a small ulcer may have extensive deep space involvement. Diabetic patients may not mount a typical inflammatory response. Low threshold for imaging and surgical exploration.

Key Takeaways

A wound is considered chronic if it has not healed within 4-6 weeks despite appropriate care; this should trigger systematic evaluation for underlying etiology.
The “Big Four” causes of chronic lower extremity wounds are venous insufficiency (70%), arterial disease (10-15%), diabetic neuropathy, and pressure — these account for the vast majority of cases.
Location is the strongest clue to etiology: medial lower leg suggests venous disease; toes and heel suggest arterial disease; plantar surface suggests diabetic neuropathy; bony prominences suggest pressure injury.
The ankle-brachial index (ABI) is essential before initiating compression therapy for leg ulcers — compression in the setting of arterial disease can cause critical limb ischemia.
Always check for mixed etiology (15-20% of chronic wounds) — finding venous disease does not exclude concurrent arterial disease.
Chronic wounds are characterized by persistent inflammation, elevated matrix metalloproteinases, biofilm formation, and senescent cells — understanding these mechanisms guides advanced therapies.
Atypical features (rapid progression, raised edges, pathergy, systemic symptoms) should prompt biopsy to exclude malignancy, vasculitis, pyoderma gangrenosum, and other uncommon causes.
Wound dressings do not heal chronic wounds — treatment of the underlying cause (compression, offloading, revascularization, pressure relief) is always the priority.
Any wound not improving after 6 weeks of appropriate treatment should be biopsied to exclude malignancy (squamous cell carcinoma, Marjolin ulcer).
Secondary prevention is essential after healing — recurrence rates for chronic wounds are high without ongoing preventive measures (compression stockings, protective footwear, pressure redistribution).

Quick Reference Algorithm

Systematic Approach to Non-Healing Wounds:

Assess urgency: Rule out emergencies (necrotizing infection, acute ischemia, sepsis) — if present, act immediately
Evaluate perfusion: Check pulses and ABI — if arterial disease present, revascularization may be required before wound can heal
Identify etiology: Use location, wound characteristics, and patient history to determine cause (venous, arterial, diabetic, pressure, or other)
Assess for infection: Clinical signs of infection require treatment — use tissue culture, not surface swabs; consider osteomyelitis if bone involved
Address the underlying cause: Compression for venous, offloading for diabetic, revascularization for arterial, pressure redistribution for pressure injury
Optimize wound bed: Use TIME framework — remove non-viable Tissue, control Infection/Inflammation, balance Moisture, promote Edge advancement
Optimize systemic factors: Glycemic control, nutritional support, smoking cessation, medication review
Monitor progress: Measure wound at each visit — if not improving by 4-6 weeks, reassess diagnosis and consider biopsy
Consider advanced therapies: For wounds not responding to standard care — negative pressure wound therapy, bioengineered skin substitutes, hyperbaric oxygen (for select indications)
Plan for secondary prevention: After healing, implement lifelong preventive measures to reduce recurrence risk

Quick Reference: Compression Therapy Safety

ABI Value	Interpretation	Compression Recommendation
Greater than 1.3	Calcified vessels (unreliable ABI)	Use toe-brachial index instead; clinical assessment; caution with compression
0.9 – 1.3	Normal arterial supply	Full compression safe (30-40 mmHg)
0.8 – 0.9	Mild arterial disease	Full compression usually safe; monitor closely
0.5 – 0.8	Moderate arterial disease (mixed ulcer)	Modified compression only (20-30 mmHg); vascular referral; may need revascularization
Less than 0.5	Severe arterial disease / Critical limb ischemia	NO compression — contraindicated; urgent vascular referral for revascularization

Quick Reference: Diabetic Foot Infection Severity

Severity	Clinical Features	Setting	Management Principles
Uninfected	No purulence or signs of inflammation	Outpatient	Offloading, wound care, glycemic control; no antibiotics
Mild	Local infection only: erythema less than 2 cm, superficial	Outpatient	Oral antibiotics (1-2 weeks); wound care; close follow-up (48-72 hours)
Moderate	Erythema greater than 2 cm or deep tissue involvement (abscess, osteomyelitis)	Consider admission	IV antibiotics; imaging; surgical debridement if abscess; glycemic control
Severe	Systemic signs: fever, tachycardia, hypotension, confusion, leukocytosis	Admission mandatory	IV antibiotics; urgent surgical debridement; ICU if septic; may need amputation